Skip to main content
Clinical Trials/CTRI/2025/08/092850
CTRI/2025/08/092850
Not yet recruiting
Phase 2/3

A Randomoised,Prospective, Double Blinded Study To Compare The Efficacy Of Ultrasound Guided Transversus Abdominis Plane Block and Erector Spinae Plane Block in Minimally Invasive Nephrectomy Surgeries

SRM Institutes For Medical Sciences1 site in 1 country50 target enrollmentStarted: August 22, 2025Last updated:

Overview

Phase
Phase 2/3
Status
Not yet recruiting
Sponsor
SRM Institutes For Medical Sciences
Enrollment
50
Locations
1
Primary Endpoint
1)To observe intraoperative Remifentanil requirement and the pain score using Visual Analog Scale (VAS) score for first 24 hours,postoperative Tramadol requirement for first 24 hours

Overview

Brief Summary

This study is a randomised ,prospective,double blinded comparing the efficacy of ultrasound guided Transversus Abdominis Plane Block and Erector Spinae Plane Block in Minimally Invasive Nephrectomy Surgeries.Primary outcomes will be intraoperative Remifentanil requiremet,the pain score using Visual Analog Scale (VAS) score for first 24 hours,the postoperative Tramadol requirement for first 24 hours.secondary outcomes will be the incidence of hemodynamic disturbances during perioperative period,the incidence of side effects of opioids such as postoperative nausea, vomiting, sedation and respiratory depression.

Study Design

Study Type
Interventional
Allocation
Coin toss, Lottery, toss of dice, shuffling cards etc
Masking
Participant and Investigator Blinded

Eligibility Criteria

Ages
20.00 Year(s) to 70.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • ASA grade 1 and 2,Any gender ,Age 20 to 70 years ,BMI 18 to 30 ,Patients willing to participate in the study ,Patients admitted for minimally invasive nephrectomy surgery ,No history of allergy to Local anaesthetics.

Exclusion Criteria

  • ASA grade 3, 4, 5,Pregnant and lactating mother,Age less than 20 years and more than 70 years,Obese individuals with BMI more than 30,Chronic history of Opioid abuse,History of allergy to Local anaesthetics,Patients not willing to participate in this study.

Outcomes

Primary Outcomes

1)To observe intraoperative Remifentanil requirement and the pain score using Visual Analog Scale (VAS) score for first 24 hours,postoperative Tramadol requirement for first 24 hours

Time Frame: 12 months

Secondary Outcomes

  • 1) To observe the incidence of hemodynamic disturbances during perioperative period(2) To observe the incidence of side effects of opioids such as postoperative nausea, vomiting, sedation and respiratory depression)

Investigators

Sponsor
SRM Institutes For Medical Sciences
Sponsor Class
Private hospital/clinic
Responsible Party
Principal Investigator
Principal Investigator

shanmugapriya g

SRM INSTITUTES FOR MEDICAL SCIENCES

Study Sites (1)

Loading locations...

Similar Trials